Gold prices edge higher on raised Fed rate cut hopes
Investing.com - Clearpoint Neuro reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Clearpoint Neuro announced earnings per share of $-0.15 on revenue of $5.1M. Analysts polled by Investing.com EPS of $-0.19 on revenue of $5.41M.
Clearpoint Neuro 's are down 35% and is trading at $10.90 , still down 48.46% from its 52 week high of $19.50 set on Wednesday, November 10, 2021.
Clearpoint Neuro shares gained 8.46% to trade at $10.90 in after-hours trade the report.
Clearpoint Neuro follows other major Healthcare sector earnings this month
Clearpoint Neuro's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar